Table 2

Bacterial isolates and susceptibility patterns among study population
GEN CRX CHLO CTR CTX AMP TET COT PEN FLX ERY
Bacteria isolates N n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%) n(%)
Salmonella spp 8 - - 5(62.5) 8(100.0) 8(100.0) 0(0.0) 0(0.0) 0(0.0) - - -
Klebsiella spp 12 4(33.3) 1(8.3) 5(41.7) 11(91.7) 11(91.7) 0(0.0) 1(8.3) 0(0.0) - - -
Escherichia coli 6 4(66.7) 4(66.7) 2(33.3) 4(66.7) 4(66.7) 2(33.3) 1(16.7) 2(33.3) - - -
Acinetobacter spp 2 2(100.0) 0(0.0) 0(0.0) 2(100) 2(100.0) 0(0.0) 0(0.0) 0(0.0) - - -
Pseudomonas aeruginosa 3 1(33.3) - - 1(33.3) 1(33.3) - - - - - -
Coagulase negative Staphylococci 25 18(72.0) 14(56.0) - - - 1(4.0) 6(24.0) 5(20.0) 1(4.0) 10(40.0) 13(52.0)
Coagulase positive Staphylococci 28 12(42.9) 16(57.1) - - - 1(3.6) 2(25) 2(7.1) 1(3.6) 8(28.6) 10(35.7)

GEN –Gentamicin, CRX-Cefuroxime, CHLO-Chloramphenicol, CTR-Ceftriaxone, CTX- Cefotaxime, AMP-Ampicillin, TET- Tetracycline, COT-Cotrimoxazole, PEN- Penicillin, FLX-Flucloxacillin, ERY- Erythromycin, (-) – Not done, Salmonella spp= Salmonella spp and Salmonella typhi, Klebsiella spp = Klebsiella spp and Klebsiella pneumoniae.

Acquah et al.

Acquah et al. BMC Infectious Diseases 2013 13:89   doi:10.1186/1471-2334-13-89

Open Data